Marked response to pembrolizumab in a patient with pulmonary pleomorphic carcinoma highly positive for PD-L1

Yuki Ikematsu, Yasuto Yoneshima, Kayo Ijichi, Kentaro Tanaka, Taishi Harada, Yoshinao Oda, Yoichi Nakanishi, Isamu Okamoto

研究成果: Contribution to journalLetter

14 引用 (Scopus)
元の言語英語
ページ(範囲)230-231
ページ数2
ジャーナルLung Cancer
112
DOI
出版物ステータス出版済み - 10 2017

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

これを引用